302 related articles for article (PubMed ID: 20056955)
1. C-reactive protein and the risk of cancer: a mendelian randomization study.
Allin KH; Nordestgaard BG; Zacho J; Tybjaerg-Hansen A; Bojesen SE
J Natl Cancer Inst; 2010 Feb; 102(3):202-6. PubMed ID: 20056955
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
3. Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population.
Marott SC; Nordestgaard BG; Zacho J; Friberg J; Jensen GB; Tybjaerg-Hansen A; Benn M
J Am Coll Cardiol; 2010 Aug; 56(10):789-95. PubMed ID: 20797493
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and risk of venous thromboembolism in the general population.
Zacho J; Tybjaerg-Hansen A; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1672-8. PubMed ID: 20466978
[TBL] [Abstract][Full Text] [Related]
5. Plasma C-reactive protein and risk of cancer: a prospective study from Greece.
Trichopoulos D; Psaltopoulou T; Orfanos P; Trichopoulou A; Boffetta P
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):381-4. PubMed ID: 16492932
[TBL] [Abstract][Full Text] [Related]
6. Genetic and biochemical markers of obstructive lung disease in the general population.
Dahl M
Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein e genotype, plasma cholesterol, and cancer: a Mendelian randomization study.
Trompet S; Jukema JW; Katan MB; Blauw GJ; Sattar N; Buckley B; Caslake M; Ford I; Shepherd J; Westendorp RG; de Craen AJ
Am J Epidemiol; 2009 Dec; 170(11):1415-21. PubMed ID: 19889709
[TBL] [Abstract][Full Text] [Related]
8. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J
J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
[TBL] [Abstract][Full Text] [Related]
11. Elevated C-reactive protein, depression, somatic diseases, and all-cause mortality: a mendelian randomization study.
Wium-Andersen MK; Orsted DD; Nordestgaard BG
Biol Psychiatry; 2014 Aug; 76(3):249-57. PubMed ID: 24246360
[TBL] [Abstract][Full Text] [Related]
12. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.
Allin KH; Nordestgaard BG
Crit Rev Clin Lab Sci; 2011; 48(4):155-70. PubMed ID: 22035340
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein as a predictor of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) cohort.
Cheung BM; Ong KL; Tso AW; Leung RY; Xu A; Cherny SS; Sham PC; Lam TH; Lam KS
J Hum Hypertens; 2012 Feb; 26(2):108-16. PubMed ID: 21270838
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
[TBL] [Abstract][Full Text] [Related]
15. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study.
Bos MJ; Schipper CM; Koudstaal PJ; Witteman JC; Hofman A; Breteler MM
Circulation; 2006 Oct; 114(15):1591-8. PubMed ID: 17015791
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein and risk of breast cancer.
Zhang SM; Lin J; Cook NR; Lee IM; Manson JE; Buring JE; Ridker PM
J Natl Cancer Inst; 2007 Jun; 99(11):890-4. PubMed ID: 17551149
[TBL] [Abstract][Full Text] [Related]
17. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality.
Davey Smith G; Lawlor DA; Harbord R; Timpson N; Rumley A; Lowe GD; Day IN; Ebrahim S
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1051-6. PubMed ID: 15731495
[TBL] [Abstract][Full Text] [Related]
18. C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach.
Dahl M; Vestbo J; Zacho J; Lange P; Tybjærg-Hansen A; Nordestgaard BG
Thorax; 2011 Mar; 66(3):197-204. PubMed ID: 21059738
[TBL] [Abstract][Full Text] [Related]
19. Association of common CRP gene variants with CRP levels and cardiovascular events.
Miller DT; Zee RY; Suk Danik J; Kozlowski P; Chasman DI; Lazarus R; Cook NR; Ridker PM; Kwiatkowski DJ
Ann Hum Genet; 2005 Nov; 69(Pt 6):623-38. PubMed ID: 16266402
[TBL] [Abstract][Full Text] [Related]
20. Mendelian randomization study of interleukin-6 in chronic obstructive pulmonary disease.
van Durme YM; Lahousse L; Verhamme KM; Stolk L; Eijgelsheim M; Loth DW; Uitterlinden AG; Breteler MM; Joos GF; Hofman A; Stricker BH; Brusselle GG
Respiration; 2011; 82(6):530-8. PubMed ID: 21997388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
